Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20).
Masahiro SekimizuReiji FukanoYuhki KogaTetsuo MitsuiNaoto FujitaTakeshi MoriDaiki HoriMakito TanakaKentaro OhkiHideto IwafuchiAtsuko NakazawaTetsuya MoriRyoji KobayashiMasahide OkiAkiko M SaitoMichi Kameinull nullPublished in: BMJ open (2024)
Japan Registry of Clinical Trials, jRCTs041210104.
Keyphrases
- open label
- clinical trial
- phase ii study
- study protocol
- phase ii
- phase iii
- newly diagnosed
- diffuse large b cell lymphoma
- young adults
- randomized controlled trial
- locally advanced
- double blind
- papillary thyroid
- placebo controlled
- childhood cancer
- mental health
- squamous cell
- emergency department
- intensive care unit
- squamous cell carcinoma
- rectal cancer
- radiation therapy
- hodgkin lymphoma
- lymph node metastasis